OU Health marked a significant breakthrough for Oklahoma in lung cancer treatment, becoming the first health care system in ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...

OU Health has become the first health system in Oklahoma to use Cytalux, a groundbreaking technology that helps detect cancer cells during surgery.

Other causes of lung cancer are well known, like radon gas exposure, which happens to be fairly prevalent in Appalachia. It’s ...

During a Case-Based Roundtable® event, Patrick M. Forde, MD, discussed safety and tolerability concerns with immunotherapy in ...

“This discovery opens up a new avenue for cancer treatment,” Dr. Ankit Bharat ... and we specifically saw a response with ...

Lung cancer treatment has advanced, but it remains a leading cause of death due to late detection, treatment resistance, and ...

Smoking leads to cancer. That's known. But what new research shows is quitting smoking soon after a diagnosis helps patients ...

Treatment for oncogene-driven lung cancer often begins with targeted therapy, which tends to offer benefits over chemotherapy ...

Chavez, MD, discusses the current approach to managing recurrent small cell lung cancer especially in patients who have ...

Thanks to advances in medicine, an Arkansas man was able to get diagnosed and overcome stage 4 lung cancer. Now, he's sharing ...